Why this collection exists
Cell and gene therapy is fragmented across tools, suppliers, and platform companies. This collection turns that sprawl into a more usable shortlist.
Best fit
Use it for market scans, vendor discovery, and future editorial roundups around CRISPR, vectors, and manufacturing support.
